FDA has also declared psilocybin a breakthrough therapy for treatment-resistant depression and just recently approved esketamine for depression.
FDA har også erklæret psilocybin et terapeutisk gennembrud. for behandlingsresistent depression og godkendte for nylig eskatemin for depression.